TianYu Bio-Technology Co., Ltd. Class A

TianYu Bio-Technology Co., Ltd. Class A

SSSE:603717
5.02
CNY
-0.18
(-3.46%)
-0.66EPS
1.75BMarket Cap

Total Valuation

CNY

As of September 30, 2026, TianYu Bio-Technology Co., Ltd. Class A carries a market capitalization of 1.75B, placing it among publicly traded companies globally. Its enterprise value stands at 2.84B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.75B
Enterprise Value2.84B

Share Statistics

As of September 30, 2026, TianYu Bio-Technology Co., Ltd. Class A has 290.15M shares outstanding.

Shares Outstanding290.15M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 2.44, and the price-to-book ratio stands at 5.75.

PS Ratio2.44
PB Ratio5.75
P/TBV Ratio6.29

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 3.98 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.84B versus a market cap of 1.75B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales3.98

Financial Position

As of September 30, 2026, TianYu Bio-Technology Co., Ltd. Class A maintains a current ratio of 0.85, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 205.41, indicating elevated leverage, while an interest coverage ratio of -4.37 demonstrates limited ability to service its debt obligations.

Current Ratio0.85
Quick Ratio0.14
Debt / Equity205.41
Debt / EBITDA-5.66
Interest Coverage-4.37

Financial Efficiency

CNY

These figures cover the twelve months ended September 30, 2026. The company generates approximately 1.43M in revenue per employee across its workforce of 500.00, a quick read on workforce productivity versus industry peers.

Revenue Per Employee1.43M
Employee Count500.00

Taxes

CNY

Over the twelve months ended September 30, 2026, TianYu Bio-Technology Co., Ltd. Class A recorded 2.88M in income tax expense. The company reported a pretax loss of -189.26M and -194.13M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax2.88M

Stock Price Statistics

CNY

As of the close on November 17, 2026, TianYu Bio-Technology Co., Ltd. Class A's stock has declined approximately 49.45% over the past 52 weeks. The 50-day moving average sits at 5.73, while the 200-day moving average is 6.53.

52-Week Price Change-49.45%
50-Day Moving Average5.73
200-Day Moving Average6.53

Income Statement

CNY

Over the twelve months ended September 30, 2026, TianYu Bio-Technology Co., Ltd. Class A generated 714.30M in revenue and converted that into -194.13M in net income, yielding earnings per share of -0.66. EBITDA reached -187.01M, while operating income came in at -165.20M.

Revenue714.30M
Gross Profit-78.72M
Operating Income-165.20M
Pretax Income-189.26M
Net Income-194.13M
EBITDA-187.01M
EBIT-187.01M
Earnings Per Share (EPS)-0.66

Balance Sheet

CNY

As of September 30, 2026, TianYu Bio-Technology Co., Ltd. Class A holds 172.99M in cash and equivalents against 1.06B in total debt, resulting in a net debt position of 610.12M. Total book value stands at 303.52M, with working capital of -183.15M providing operational flexibility.

Cash & Cash Equivalents172.99M
Total Debt1.06B
Net Debt610.12M
Equity (Book Value)303.52M
Book Value Per Share1.05
Working Capital-183.15M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-24.82M

Margins

Over the twelve months ended September 30, 2026, TianYu Bio-Technology Co., Ltd. Class A posted a gross margin of -11.02, reflecting its pricing power and cost economics. The operating margin of -23.13 and net profit margin of -27.18 provide insight into operational efficiency.

Gross Margin-11.02
Operating Margin-23.13
Pretax Margin-26.50
Profit Margin-27.18
EBITDA Margin-26.18

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, TianYu Bio-Technology Co., Ltd. Class A paid dividends of 0.12 per share. The dividend payout ratio of -18.00 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 5.67, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to TianYu Bio-Technology Co., Ltd. Class A shareholders.

Dividend Per Share0.12
Payout Ratio-18.00
Shareholder Yield5.67

Stock Splits

TianYu Bio-Technology Co., Ltd. Class A's most recent stock split took place on June 8, 2018 with a 5:7 split ratio.

Last Split Date6/8/2018
Split Ratio5:7

Scores

As of September 30, 2026, TianYu Bio-Technology Co., Ltd. Class A has an Altman Z-Score of -0.02, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.02